Papers of the Week

< BACK TO ARCHIVE

DATE PUBLISHED:
2022 May 26

JOURNAL:
Dermatol Surg

PUBMED:
http://www.ncbi.nlm.nih.gov/pubmed/35616616?dopt=Abstract

PrabotulinumtoxinA for Treatment of Millennials With Moderate to Severe Glabellar Lines: Post Hoc Analyses of the Phase III Clinical Study Data.

Authors

PrabotulinumtoxinA for Treatment of Millennials With Moderate to Severe Glabellar Lines: Post Hoc Analyses of the Phase III Clinical Study Data.

Ogilvie P, Jones DH, Avelar RL, Jonker A, Monroe R, Carruthers J

Dermatol Surg. 2022 May 26.

PMID: 35616616.

Abstract

The use of esthetic products by millennials is increasing, yet published clinical trial data in this population are limited.

Read This Paper